Evidence map›Paper›PMID 28942427›Full record

ArticleCirculation2017

Binding of FUN14 Domain Containing 1 With Inositol 1,4,5-Trisphosphate Receptor in Mitochondria-Associated Endoplasmic Reticulum Membranes Maintains Mitochondrial Dynamics and Function in Hearts in Vivo.

Shengnan Wu, Qiulun Lu, Qilong Wang, Ye Ding, Zejun Ma, Xiaoxiang Mao, Kai Huang, Zhonglin Xie, Ming-Hui Zou

Open access · greenAbstract read
In one paragraph

Article in Circulation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 198 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
198citing papers in PubMed, 2 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

198 citing papers in PubMed, 2 syntheses or guidelines pooled it, 307 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Mitophagy coordinates organelle crosstalk in health and diseases.Signal transduction and targeted therapy · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Organelle contact sites in cancer cells.Cell death & disease · 2026
    Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

138 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shengnan WuCenter for Molecular and Translational Medicine, Georgia State University, Atlanta (S.W., Q.L., Q.W., Y.D., Z.M., Z.X., M.-H.Z.). Wuhan Union Hospital, Huazhong University of Science and Technology, Hubei, China (X.M., K.H.).
Qiulun LuCenter for Molecular and Translational Medicine, Georgia State University, Atlanta (S.W., Q.L., Q.W., Y.D., Z.M., Z.X., M.-H.Z.). Wuhan Union Hospital, Huazhong University of Science and Technology, Hubei, China (X.M., K.H.).
Qilong WangCenter for Molecular and Translational Medicine, Georgia State University, Atlanta (S.W., Q.L., Q.W., Y.D., Z.M., Z.X., M.-H.Z.). Wuhan Union Hospital, Huazhong University of Science and Technology, Hubei, China (X.M., K.H.).
Ye DingCenter for Molecular and Translational Medicine, Georgia State University, Atlanta (S.W., Q.L., Q.W., Y.D., Z.M., Z.X., M.-H.Z.). Wuhan Union Hospital, Huazhong University of Science and Technology, Hubei, China (X.M., K.H.).
Zejun MaCenter for Molecular and Translational Medicine, Georgia State University, Atlanta (S.W., Q.L., Q.W., Y.D., Z.M., Z.X., M.-H.Z.). Wuhan Union Hospital, Huazhong University of Science and Technology, Hubei, China (X.M., K.H.).
Xiaoxiang MaoCenter for Molecular and Translational Medicine, Georgia State University, Atlanta (S.W., Q.L., Q.W., Y.D., Z.M., Z.X., M.-H.Z.). Wuhan Union Hospital, Huazhong University of Science and Technology, Hubei, China (X.M., K.H.).
Kai HuangCenter for Molecular and Translational Medicine, Georgia State University, Atlanta (S.W., Q.L., Q.W., Y.D., Z.M., Z.X., M.-H.Z.). Wuhan Union Hospital, Huazhong University of Science and Technology, Hubei, China (X.M., K.H.).
Zhonglin XieCenter for Molecular and Translational Medicine, Georgia State University, Atlanta (S.W., Q.L., Q.W., Y.D., Z.M., Z.X., M.-H.Z.). Wuhan Union Hospital, Huazhong University of Science and Technology, Hubei, China (X.M., K.H.). mzou@gsu.edu zxie@gsu.edu.
Ming-Hui ZouCenter for Molecular and Translational Medicine, Georgia State University, Atlanta (S.W., Q.L., Q.W., Y.D., Z.M., Z.X., M.-H.Z.). Wuhan Union Hospital, Huazhong University of Science and Technology, Hubei, China (X.M., K.H.). mzou@gsu.edu zxie@gsu.edu.
Union Hospital · CNUnion Hospital · CN

Funding

Reactive Nitrogen species and Diabetic Endothelial DysfunctionR01HL079584 · NHLBI · UNIVERSITY OF TENNESSEE KNOXVILLE · PI ZOU, MING-HUI · 2004 to 2021
$7.3M
Inflammasome and unstable atherosclerotic plaquesR01HL089920 · NHLBI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ZOU, MING-HUI · 2008 to 2022
$6.9M
AMP-Activated Protein Kinase in DiabetesR01HL080499 · NHLBI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ZOU, MING-HUI · 2006 to 2019
$5.8M
Controlling VSMC Proliferation and MigrationR01HL110488 · NHLBI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ZOU, MING-HUI · 2011 to 2020
$3.9M
Oxidant stress and diabetic endothelial dysfunctionR01HL074399 · NHLBI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ZOU, MING-HUI · 2005 to 2013
$3.2M
SNRK in ischemic vascular diseasesR01HL142287 · NHLBI · GEORGIA STATE UNIVERSITY · PI XIE, ZHONGLIN, ZOU, MING-HUI · 2018 to 2022
$3.0M
FUNDC1 and diabetic cardiomyopathyR01HL137371 · NHLBI · GEORGIA STATE UNIVERSITY · PI XIE, ZHONGLIN, ZOU, MING-HUI · 2017 to 2020
$2.8M
Autophagy and VSMC migrationR01HL132500 · NHLBI · GEORGIA STATE UNIVERSITY · PI XIE, ZHONGLIN, ZOU, MING-HUI · 2016 to 2019
$2.7M
Suppression of Autophagy-Dependent Clearance Mitochondria in Type 2 DiabetesR01HL128014 · NHLBI · GEORGIA STATE UNIVERSITY · PI XIE, ZHONGLIN, ZOU, MING-HUI · 2015 to 2018
$2.4M
Liver kinase B1 in angiogenesisR01CA213022 · NCI · GEORGIA STATE UNIVERSITY · PI ZOU, MING-HUI · 2017 to 2021
$2.3M
Sirt1, Vascular Aging, and Aortic AneurysmR01AG047776 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ZOU, MING-HUI · 2014 to 2018
$1.5M
NCI NIH HHS R01 CA213022NHLBI NIH HHS R01 HL074399NHLBI NIH HHS R01 HL079584NHLBI NIH HHS R01 HL080499NHLBI NIH HHS R01 HL089920NHLBI NIH HHS R01 HL110488NHLBI NIH HHS R01 HL128014NHLBI NIH HHS R01 HL132500NHLBI NIH HHS R01 HL137371NHLBI NIH HHS R01 HL142287NIA NIH HHS R01 AG047776
6 · The paper itself

Abstract

backgroundFUN14 domain containing 1 (FUNDC1) is a highly conserved outer mitochondrial membrane protein. The aim of this study is to examine whether FUNDC1 modulates the mitochondria-associated endoplasmic reticulum (ER) membranes (MAMs), mitochondrial morphology, and function in cardiomyocytes and intact hearts.

methodsThe impacts of FUNDC1 on MAMs formation and cardiac functions were studied in mouse neonatal cardiomyocytes, in mice with cardiomyocyte-specific

resultsIn mouse neonatal cardiomyocytes and intact hearts, FUNDC1 was localized in MAMs by binding to ER-resided inositol 1,4,5-trisphosphate type 2 receptor (IP

conclusionsWe conclude that FUNDC1 binds to IP

Indexed as

Mitochondrial DynamicsAnimalsBinding SitesCalciumCase-Control StudiesCells, CulturedCyclic AMP Response Element-Binding ProteinEndoplasmic ReticulumGenetic Predisposition to DiseaseHeart FailureHumansInositol 1,4,5-Trisphosphate ReceptorsIntracellular MembranesMembrane ProteinsMice, KnockoutMitochondria, HeartCalciumCREB1 protein, humanCreb1 protein, mouseCyclic AMP Response Element-Binding ProteinFIS1 protein, humanFIS1 protein, mouseFUNDC1 protein, humanFUNDC1 protein, mouseInositol 1,4,5-Trisphosphate ReceptorsIp3r2 protein, mouseITPR2 protein, humanMembrane ProteinsMitochondrial ProteinscardiomyopathyFUNDC1heart failureIP3R2MAMs

Identifiers

PMID28942427
PMCPMC5716911
OpenAlexW2760395470

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.